Search PDMR transactions

Notifier
Name of person with notification obligation
Nicklas Westerholm
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Nicklas Westerholm
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB (publ)
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Egetis Therapeutics AB SE0003815604 Acquisition 19,600 Quantity 6.10 SEK 23/02/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Egetis Therapeutics AB SE0003815604 Acquisition 23/02/2024 NASDAQ STOCKHOLM AB 19,600 (Quantity) 6.10 SEK
Total: 19,600
<< Back